2008

November 10, 2008
Precision secures $43 million in funding

September 5, 2008
Watch! Individualized Treatment for Cancer Catching On

July 10, 2008
Precision publishes new article in Cancer Cell International

July, 2008
Precision's Quarterly Newsletter

July 1, 2008
Precision announces study results: ChemoFx^® correlates with outcomes in breast cancer

June 30, 2008
Sean McDonald named Entrepreneur of the Year winner

May 20, 2008
Precision announces study results at ASCO: ChemoFx correlates with survival in ovarian cancer

April 2008
Precision's Quarterly Newsletter

April 8, 2008
Precision Adds 8 Million Covered Lives Under Contract

2007

December 4, 2007
Oracle Healthcare and Precision Therapeutics Announce Merger

October 2007
Precision announces study results with independent cytopathologist

August 2, 2007
Genetic tests for treatment growing part of health care field

July 11, 2007
Making Medicine Personal

May 7, 2007
Precision Therapeutics Hires Matt Marshall as Vice President

2006

February 22, 2006
Precision Therapeutics Gets $20M Series B For Growth

February 22, 2006
Precision's Series B Adds $20M For Cancer Regimen

February 18, 2006
Company gets $20M in venture capital

February 15, 2006
Finding The Best Treatment For Recurrent Ovarian Cancer

January 31, 2006
ChemoFx^® improves therapy effectiveness for ovarian cancer patients